Balaji Amines Limited (BOM:530999)

Market Cap	58.27B
Revenue (ttm)	13.97B
Net Income (ttm)	1.58B
Shares Out	32.40M
EPS (ttm)	48.62
PE Ratio	36.99
Forward PE	28.30
Dividend	11.00 (0.61%)
Ex-Dividend Date	Jul 4, 2024

Volume	30,417
Average Volume	19,776
Open	1,833.95
Previous Close	1,828.00
Day's Range	1,754.30 - 1,875.00
52-Week Range	1,112.00 - 2,550.15
Beta	0.58
RSI	72.52
Earnings Date	Aug 8, 2025

About Balaji Amines

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene...

• Industry: Industrial Organic Chemicals
• Founded: 1988
• Employees: 1,084
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 530999

Financial Performance

In 2024, Balaji Amines's revenue was 13.97 billion, a decrease of -14.89% compared to the previous year's 16.42 billion. Earnings were 1.58 billion, a decrease of -23.11%.